Submission of Letter of Offer regarding the open offer for acquisition of fully paid-up equity shares of Bliss GVS Pharma Limited from the Public Shareholders, by the Company together with PAC
M&A
◆ Monitor Closely
MEDIUM RISK
📅 Filed on BSE: 21 Jul 2026, 09:22 PM IST · BSE ID: 6dbe5ce5-01db-415a-9f9e-150e6ef07030
View Original BSE Filing (PDF)
💡
In Simple Terms
Anupam Rasayan submitted documents for its offer to buy 26.00% of Bliss GVS Pharma shares from public shareholders.
🤖 AI Summary
- Anupam Rasayan India Ltd submitted the Letter of Offer for its open offer to acquire 26.00% of Bliss GVS Pharma Limited.
- The open offer targets up to 2,77,26,848 fully paid-up equity shares of Bliss GVS Pharma.
- The offer price for each equity share is ₹ 299.00, to be paid in cash.
- Anupam Rasayan India Limited is the acquirer, with Mates Visa Consultancy Private Limited acting as a Person Acting in Concert (PAC).
🔢 Key Numbers — exact figures from BSE filing, not rounded
Offer Share Capital Percentage
26.00%
Total Offer Shares
2,77,26,848
Offer Price per Equity Share
₹ 299.00
Face Value per Equity Share
₹ 1
🏢 How This Affects the Company
This formal submission progresses Anupam Rasayan's strategic acquisition of Bliss GVS Pharma, potentially expanding its market presence and product portfolio.
The cash offer for 2,77,26,848 equity shares at ₹ 299.00 each indicates a substantial cash outflow for Anupam Rasayan.
The completion of the open offer will introduce Bliss GVS Pharma's operational risks and market exposure into Anupam Rasayan's overall risk profile.
👥 What This Means For Shareholders
✅
Action Required
Public shareholders of Bliss GVS Pharma Limited who wish to tender their shares in the Open Offer must review the Letter of Offer and submit the Form of Acceptance-cum-Acknowledgement.
👤
Who Is Affected
Public shareholders of Bliss GVS Pharma Limited are offered the opportunity to sell up to 2,77,26,848 of their fully paid-up equity shares at ₹ 299.00 per share.
🔍
Management Signal
The submission of the Letter of Offer signals Anupam Rasayan's commitment to proceed with the previously announced acquisition of Bliss GVS Pharma.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Tendering period dates for the open offer from public shareholders of Bliss GVS Pharma.
Announcement of the final acquisition status and shareholding post-open offer.
Any further regulatory approvals or updates regarding the open offer terms.
MEDIUM RISK
Acquisition and open offer processes involve execution risks and integration challenges.
💡 Investor Takeaway
Anupam Rasayan India Ltd has submitted the Letter of Offer for its open offer to acquire 26.00% of Bliss GVS Pharma Limited. The cash offer is for up to 2,77,26,848 equity shares at ₹ 299.00 per equity share.
⚖️ Strengths & Concerns
✅ Positives
- Formal submission of the Letter of Offer indicates progress towards the strategic acquisition, maintaining deal momentum.
- The open offer aims to acquire a significant 26.00% stake, enhancing Anupam Rasayan's control and influence over Bliss GVS Pharma.
⚠️ Concerns
- The cash offer for 2,77,26,848 shares at ₹ 299.00 per share will require significant funding, impacting Anupam Rasayan's cash reserves.
- Integration challenges or unexpected liabilities from Bliss GVS Pharma could present new operational or financial concerns for Anupam Rasayan.
📅 Company Track Record
Anupam Rasayan India Ltd had previously filed the Draft Letter of Offer on 2026-06-09 for a 26.00% open offer of Bliss GVS Pharma at ₹ 299.00 per share. On 2026-07-17, the company announced the acquisition of Mates Visa Consultancy for INR 10,000, which is acting as a PAC for this acquisition.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What is the purpose of Anupam Rasayan's latest filing regarding Bliss GVS Pharma?
Anupam Rasayan India Ltd has submitted the Letter of Offer for its open offer to acquire fully paid-up equity shares of Bliss GVS Pharma Limited from public shareholders.
What percentage of Bliss GVS Pharma is Anupam Rasayan seeking to acquire through the open offer?
Anupam Rasayan India Ltd, along with Mates Visa Consultancy Private Limited (PAC), is making a cash offer to acquire up to 26.00% of the Expanded Voting Share Capital of Bliss GVS Pharma Limited.
What is the offer price per equity share in Anupam Rasayan's open offer for Bliss GVS Pharma?
The offer price for each fully paid-up equity share of Bliss GVS Pharma Limited is ₹ 299.00.
How many equity shares are targeted in the open offer for Bliss GVS Pharma?
The open offer by Anupam Rasayan India Limited aims to acquire up to 2,77,26,848 fully paid-up equity shares of Bliss GVS Pharma Limited.
Questions based on this BSE filing only. For information purposes.